Cologuard® Blitzes the Marketplace at J.P. Morgan

It’s Super Bowl Sunday in Arizona this weekend, but the healthcare industry’s Super Bowl played out earlier this month at the J.P. Morgan Healthcare Conference in San Francisco.

In a field crowded with established players with big news of their own, including Roche's buzz-worthy acquisition of a major stake in Foundation Medicine, Exact’s ability to deliver on our promises during the past year helped us stand out from the pack. 

After speaking at the conference in past years, this year’s presentation before a standing-room-only crowd was especially fulfilling because of the significant milestones the Exact team achieved in 2014.

This included the publication of the pivotal Deep-C study results in the New England Journal of Medicine, the FDA’s approval of Cologuard and a final CMS coverage and pricing determination. Now, less than six months after approval we are seeing rapid clinician adoption and a direct impact on patients.